Sandra Johnson Data-verified

OverviewAI-generated summary

Sandra Johnson's research has focused on the genomic epidemiology of viral infections, particularly in the context of public health responses. She has investigated the role of genomics in understanding and responding to COVID-19 outbreaks in Victoria, Australia, examining its impact on healthcare workers and informing future pandemic preparedness.

Her work also includes the pathogenesis and treatment of various diseases. This includes a comprehensive review of viral infections and glaucoma, and analyses of patient-reported outcomes from clinical trials for conditions like plaque psoriasis. Additionally, she has examined risk factors for nephrotoxicity in patients with Methicillin-Resistant Staphylococcus aureus bacteremia, utilizing data from the CAMERA2 trial. Johnson has also contributed to research on viral inactivation methods relevant to biomanufacturing.

With an h-index of 22 and over 3,900 citations across 69 publications, Johnson is recognized as a highly cited researcher. She collaborates with Sandy Johnson at the University of Arkansas – Fort Smith, with whom she shares three publications. Johnson maintains an active laboratory website.

Metrics

• h-index: 22
• Publications: 69
• Citations: 4,001